GHET1 and breast carcinoma: The prognostic value of GHET1 was investigated in seven kinds of human cancer in gastric cancer [10], lung cancer [11,12], hepatocellular carcinoma [14], breast cancer [15], esophageal squamous cell carcinoma [17], bladder cancer, [19] and head and neck cancer [20].